Home-based device to help retrain hand use after stroke
Tests a home device for hand exercise in adults with stroke-related hand weakness.
Plain-language title generated from the registry record
Registry title: Assessment of a Physio-neuro Platform (SynPhNe) for Home-based Retraining of Hand Function in Stroke Survivors
Key facts
- Where
- Boston, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 21 and 80 years old?
Source: NCT02896348, who can take part
Where in United States
- Spaulding Rehabilitation HospitalBoston, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Spaulding Rehabilitation Hospital
- Trial code
- NCT02896348
- Record updated
- 6 May 2026
- Original description
The goal of this study is to:Read full original descriptionShow less
Assessment of a Physio-neuro Platform (SynPhNe) for Home-based Retraining of Hand Function in Stroke Survivors
The goal of this study is to:
1. Assess the usability of the SynPhNe device in a home environment. 2. Evaluate the efficacy of the SynPhNe home use device to improve motor hand function in chronic stroke subjects as compared to standard care alone.
Inclusion: Ischemic or hemorrhagic stroke at least 6 months prior study enrollment ; Moderate upper-extremity hemiparesis (initial score on the Upper Extremity Fugl-Meyer Assessment between 21 and 55 out of 66) ; Ability to extend at least 2 fingers in the affected hand 10 degrees at any joint with pain-free passive range of motion at least 50% in all joints below the elbow.
Exclusion: Current participation in upper-extremity therapy program; Treatment with Botox injections in the affected arm in the previous 3 months and no planned Botox injections before the end of the study; No more than moderate impairments in paretic UE sensation, passive range of motion, and pain that would limit ability to engage in therapy; Previous diagnosis of dementia; Previous diagnosis of neurological diseases other than Stroke; Cognitive impairment resulting to inability to follow instructions (as assessed with the MMSE) and inability to sustain attention for more than 10 minutes; History of seizures disorder and/or a seizure occuring within the last 6 months; Other conditions affecting function of the stroke affected upper limb; Severe pain in the stroke affected upper limb; Terminal diseases with expected survival <1 year; Aphasia sufficient to limit comprehension and completion of the treatment protocol; Increased muscle tone as indicated by score of >/= 3 on the Modified Ashworth Scale.